The growing demand for specific immunological research and therapeutic design has spurred significant advances in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently produced using multiple expression methods, including prokaryotic hosts, animal cell lines, and baculovirus expressi